Updated on February 5, 2024

·

Created on July 25, 2017

Quicksee

Upcoming Update

The QuickSee is a portable, low-cost autorefractor based on wavefront aberrometry.

Developed By
  1. PlenOptika
Tested By
  • PlenOptika
Content Partners
Unknown

Author

Product Description

The QuickSee is a portable, low-cost autorefractor based on wavefront aberrometry—a vision care technology that scan for abnormalities in the eyeball’s optical power. As of August 2017, this product is in the manufacturing stage and is expected to launch Fall 2017. Interview with representative

Target SDGs

SDG 3: Good Health and Well-Being

Market Suggested Retail Price

$2,000.00

Target Users (Target Impact Group)

Small and Medium-sized Enterprises, Public Sector Agencies

Distributors / Implementing Organizations

PlenOptika has partnered with a reputable low-cost ophthalmic manufacturer in India called Aurolab. In the US, PlenOptika will sell and distribute the Quicksee. Interview with representative

Manufacturing/Building Method

Mass produced. PlenOptika has partnered with a reputable low-cost ophthalmic manufacturer called Aurolab

Intellectural Property Type

Patent

User Provision Model

Doctors, hospitals, and NGOs that focus on eye care can procure a Quicksee directly from Aurolab, PlenOptika's manufacturing partner, or from a sales link on the PlenOptika website. Interview with representative

Distributions to Date Status

Not applicable. As of August 2017, this product is in the manufacturing stage and is expected to launch Fall 2017. Interview with representative

Number of tests for procedure

Refractive errors test measures sphere cylinder and axis for each eye

Time required for procedure

10 seconds per eye

Diseases detected

Myopia (nearsightedness), hyperopia (farsightedness), astigmatism (light is focused unevenly on retina)

Type of technology used for test

Waveform abberometry

Design Specifications

QuickSee works by shining a light into the eye, which generates a point of light on the retina at the back of the eye. The light then bounces off the retina, and the shape of the light as it exits the eye relays information about aberrations, or distortions, that are present. To identify a patient’s prescription, a special camera called a “wavefront sensor” measures the shape of the light that comes out of the eye. Unlike a conventional camera which takes a single image, a wavefront sensor photographs the eye in segments and analyzes aberrations within each region of the eye. A computer in the device then processes all of the images collectively and calculates any refractive errors that might be present. With that, it is able to approximate a prescription in about 10 seconds per eye, which the QuickSee displays on-screen. The device can also transmit the results via Bluetooth to a smartphone or printer The Quicksee performs refractive errors tests. It measures sphere cylinder and axis for each eye and takes approximately 10 seconds per eye. The Quicksee uses waveform abberometry. It is a battery powered device and lasts 6-8 hours on a charge. measurement range— -10 to +10 diopters pupil size: 2mm-8mm The Quicksee measures roughly 14x10x5 inches and comes with a carrying case. Interview with representative

Product Schematics

Technical Support

The device can be fixed in the field by a trained service technician that works for the manufacturing partner. Customer service will be available online. An instruction manual will be provided with the device and the Quicksee will provide feedback on the screen regarding potential misuse if results seem off the mark. The time to train a technician to fix the Quicksee is about 30 minutes to two hours. Interview with representative

Replacement Components

Spare parts and batteries will be provided by the manufacturing partner. Interview with representative

Lifecycle

3-5 years Interview with representative

Manufacturer Specified Performance Parameters

The Quicksee is designed to approximate the patient's prescription as accurately as subjective and objective eye exams combined. Plenoptika started with a mission of helping the 1.5 to 2.5 billion people around the world with less-than-perfect vision obtain glasses.

Vetted Performance Status

A study conducted with 43 patients concluded that the prototype is more accurate than a state-of-the art commercial autorefractor. A 708-patient clinical trial in partnership with specialist eye care provider in Tamil Nadu, India found similar results..

Safety

The Quicksee is a medical device. Wrong readings may cause harm to the patient, as they will not receive the care that they need. An instruction manual will be provided with the device and the Quicksee will provide feedback on the screen regarding potential misuse if results seem off the mark. The Quicksee is intended for ages 5+. Interview with representative

Complementary Technical Systems

Eyeglasses

Academic Research and References

N. J. Durr, et al. “Design and Clinical Evaluation of a Handheld Wavefront Autorefractor:,” Optom. Vis. Sci., vol. 92, no. 12, pp. 1140–1147, Dec. 2015.

E. Lage, et al. “Evaluation of a low-cost wavefront aberrometer for measuring refractive errors,” in ARVO Meeting Abstracts, 2014, vol. 55, p. 2718.

E. Lage, et al. “Visual acuity evaluation with refractions prescribed by a novel low-cost wavefront analyzer,” in ARVO Meeting abstracts, 2015, vol. 56, p. 3570.

 

Review, E4C. “Fellow Visionaries.” Engineering For Change, 2019.

Compliance with regulations

PlenOptika is working toward U.S. FDA registration for the QuickSee.

Evaluation methods

Clinical Trials

Other Information

refractive errors tests measures sphere cylinder and axis for each eye 10 seconds per eye uses waveform abberometry battery powered device (6-8 hours on a charge) measurement range— -10 to +10 diopters pupil size: 2mm-8mmInterview with representative

Comments from the Community

1 Comment

  1. uitsca7 says:

    I would like to see if you are in the trial or final release stages. I distribute glasses and would love to be more accurate in eyeglass matches and want to use instrumentation that is more accurate than the methodologies we use now. Thank you. I am at +1 614-449-1095 or may be reached @ uitsca7@gmail.com.
    Thanks. Great idea!
    Carolee Uits

Leave a Reply

Explore similar solutions

Agriculture

February 26, 2024

OKIMO

Read Solution

Implemented by

Gabriela Galilea

Agriculture

February 8, 2024

GE LOGIQ V2

Read Solution

Implemented by

GE Healthcare

Agriculture

February 14, 2024

Healcerion Sonon 300C

Read Solution

Implemented by

Healcerion

Agriculture

December 12, 2023

Sohum Hearing Screening Device

Read Solution

Implemented by

Sohum Innovation lab

Agriculture

February 6, 2024

SOMATOINFRA Diagnostic System

Read Solution

Implemented by

OrthoTrauma

Agriculture

February 8, 2024

dDopp

Read Solution

Implemented by

Uni-Com Medical

Agriculture

February 15, 2024

PointCheck

Read Solution

Implemented by

Leuko

Agriculture

February 22, 2024

AyuSynk

Read Solution

Implemented by

AyuSynk

Agriculture

February 26, 2024

Zika paper-based rapid diagnostic test

Read Solution

Implemented by

Wyss Institute

Agriculture

February 26, 2024

Gazelle Diagnostic Device

Read Solution

Implemented by

Hemex Health

All Solutions

Contribute to E4C's Library of Breakthrough Sustainable Development Technology Solutions

Suggest A Solution

Get more information about Solutions Library and its features.

Learn More

Have thoughts on how we can improve?

Give Us Feedback

Join a global community of changemakers.

Become A Member